• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Stroke . Cerebrovascular Complications of COVID-19

tetano

Editor, Senior Moderator
Stroke


. 2020 Aug 6;STROKEAHA120031265.
doi: 10.1161/STROKEAHA.120.031265. Online ahead of print.
Cerebrovascular Complications of COVID-19


Jeffrey M Katz[SUP] 1 2 [/SUP], Richard B Libman[SUP] 1 [/SUP], Jason J Wang[SUP] 3 [/SUP], Pina Sanelli[SUP] 2 [/SUP], Christopher G Filippi[SUP] 2 [/SUP], Michele Gribko[SUP] 1 [/SUP], Steven V Pacia[SUP] 1 [/SUP], Ruben I Kuzniecky[SUP] 1 [/SUP], Souhel Najjar[SUP] 1 [/SUP], Salman Azhar[SUP] 1 [/SUP]



Affiliations

Abstract

Background and purpose: Coronavirus disease 2019 (COVID-19) evolved quickly into a global pandemic with myriad systemic complications, including stroke. We report the largest case series to date of cerebrovascular complications of COVID-19 and compare with stroke patients without infection.
Methods: Retrospective case series of COVID-19 patients with imaging-confirmed stroke, treated at 11 hospitals in New York, between March 14 and April 26, 2020. Demographic, clinical, laboratory, imaging, and outcome data were collected, and cases were compared with date-matched controls without COVID-19 from 1 year prior.
Results: Eighty-six COVID-19-positive stroke cases were identified (mean age, 67.4 years; 44.2% women). Ischemic stroke (83.7%) and nonfocal neurological presentations (67.4%) predominated, commonly involving multivascular distributions (45.8%) with associated hemorrhage (20.8%). Compared with controls (n=499), COVID-19 was associated with in-hospital stroke onset (47.7% versus 5.0%; P<0.001), mortality (29.1% versus 9.0%; P<0.001), and Black/multiracial race (58.1% versus 36.9%; P=0.001). COVID-19 was the strongest independent risk factor for in-hospital stroke (odds ratio, 20.9 [95% CI, 10.4-42.2]; P<0.001), whereas COVID-19, older age, and intracranial hemorrhage independently predicted mortality.
Conclusions: COVID-19 is an independent risk factor for stroke in hospitalized patients and mortality, and stroke presentations are frequently atypical.

Keywords: cerebrovascular disorders; demography; odds ratio; pandemics; risk factors.
 
Back
Top Bottom